Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1988;19:1482-1484

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lodder, J.
Right arrow Articles by van der Lugt, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lodder, J.
Right arrow Articles by van der Lugt, P. J.

Stroke, Vol 19, 1482-1484, Copyright © 1988 by American Heart Association


ARTICLES

Timing of autopsy-confirmed hemorrhagic infarction with reference to cardioembolic stroke

J Lodder, B Krijne-Kubat and PJ van der Lugt
Department of Neurology, University Hospital, Maastricht, The Netherlands.

We studied the temporal profile of hemorrhagic transformation in 34 cases with autopsy-confirmed hemorrhagic infarction who died within 15 days following a supratentorial brain infarct, provided they had undergone computed tomography. It appeared that within 4 days, at least 76% (95% confidence interval 39-100%) of 21 cardioembolic strokes had become hemorrhagic. We conclude that if anticoagulation is considered in cardioembolic stroke, such treatment should not be started sooner than at least 4 days after the onset of stroke, provided that computed tomography at that time shows no hemorrhagic infarction.


This article has been cited by other articles:


Home page
ChestHome page
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 630S - 669S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 483S - 512S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Chest, January 1, 2001; 119(1_suppl): 300S - 320S.
[Full Text] [PDF]


Home page
StrokeHome page
M. A. Sloan, T. R. Price, M. L. Terrin, S. Forman, J. M. Gore, B. R. Chaitman, M. Hodges, H. Mueller, W. J. Rogers, G. L. Knatterud, et al.
Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction : The TIMI-II Pilot and Randomized Clinical Trial Combined Experience
Stroke, June 1, 1997; 28(6): 1107 - 1114.
[Abstract] [Full Text]


Home page
StrokeHome page
C. Motto, E. Aritzu, E. Boccardi, C. De Grandi, A. Piana, and L. Candelise
Reliability of Hemorrhagic Transformation Diagnosis in Acute Ischemic Stroke
Stroke, February 1, 1997; 28(2): 302 - 306.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force
Arch Neurol, July 1, 1989; 46(7): 727 - 743.
[Abstract] [PDF]